{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:50:13Z","timestamp":1791409813855,"version":"4.3.3"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM109005"],"award-info":[{"award-number":["P20GM109005"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110399","type":"journal-article","created":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T05:46:13Z","timestamp":1787463973000},"page":"110399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of quinazoline-based dual RET\/Aurora B inhibitors for non-small cell lung cancer"],"prefix":"10.1016","volume":"181","author":[{"given":"Maha","family":"Hanafi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baha'a","family":"Jabali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva R.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Hargrove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baku","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halle","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Kanwischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashton","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Spicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Frett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bioorg.2026.110399_bb0005","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","article-title":"The global burden of lung cancer: current status and future trends","volume":"20","author":"Leiter","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110399_bb0010","article-title":"Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries","volume":"76","author":"Sung","year":"2026","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110399_bb0015","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrc3775","article-title":"Non-small-cell lung cancers: a heterogeneous set of diseases","volume":"14","author":"Chen","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110399_bb0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","article-title":"Non-small-cell lung cancer","volume":"10","author":"Hendriks","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bioorg.2026.110399_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.932353","article-title":"RET signaling pathway and RET inhibitors in human cancer","volume":"12","author":"Regua","year":"2022","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110399_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27073180","article-title":"RET signaling pathway in human cancer: oncogenic mechanisms, selective inhibitors, and emerging resistance strategies","volume":"27","author":"Streit","year":"2026","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110399_bb0035","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1158\/2159-8290.CD-19-1116","article-title":"Advances in targeting RET-dependent cancers","volume":"10","author":"Subbiah","year":"2020","journal-title":"Cancer Discov."},{"issue":"Suppl. 1","key":"10.1016\/j.bioorg.2026.110399_bb0040","article-title":"Treatment of non-small cell lung cancer with RET rearrangements","volume":"131","author":"Hoe","year":"2025","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.bioorg.2026.110399_bb0045","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.trecan.2021.07.003","article-title":"Precision therapy for RET-altered cancers with RET inhibitors","volume":"7","author":"Thein","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bioorg.2026.110399_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.109617","article-title":"Expanding landscape of kinase inhibitor research in 25 years (2001-2025) and advancements of next-generation kinase inhibitors","volume":"173","author":"Das","year":"2026","journal-title":"Bioorg. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110399_bb0055","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1021\/acs.jmedchem.3c02319","article-title":"Unraveling the promise of RET inhibitors in precision cancer therapy by targeting RET mutations","volume":"67","author":"Wang","year":"2024","journal-title":"J. Med. Chem."},{"issue":"18","key":"10.1016\/j.bioorg.2026.110399_bb0060","doi-asserted-by":"crossref","first-page":"19536","DOI":"10.1021\/acs.jmedchem.5c01777","article-title":"Discovery of APS03118, a potent and selective next-generation RET inhibitor with a novel kinase hinge scaffold","volume":"68","author":"Zhong","year":"2025","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110399_bb0065","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1158\/1535-7163.MCT-06-0301","article-title":"Frequent overexpression of aurora B kinase, a novel drug target, in non-small cell lung carcinoma patients","volume":"5","author":"Vischioni","year":"2006","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110399_bb0070","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s12672-025-02878-5","article-title":"The expression and prognosis for Aurora kinases in human non-small cell lung cancer","volume":"16","author":"Wang","year":"2025","journal-title":"Discov. Oncol."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110399_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113371","article-title":"Promising therapy in lung cancer: spotlight on Aurora kinases","volume":"12","author":"Galetta","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2026.110399_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100958","article-title":"The heterogeneous transition state of resistance to RET kinase inhibitors converges on ERK1\/2-driven Aurora a\/B kinases","volume":"68","author":"Hu","year":"2023","journal-title":"Drug Resist. Updat."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110399_bb0085","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bmc.2018.12.032","article-title":"The association between anti-tumor potency and structure-activity of protein-kinases inhibitors based on quinazoline molecular skeleton","volume":"27","author":"Li","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110399_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500279","article-title":"Recent advances of quinoline-based small molecules as kinase inhibitors (2020-2024)","author":"Sultan","year":"2025","journal-title":"ChemMedChem"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110399_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29040875","article-title":"Recent advances in structural optimization of quinazoline-based protein kinase inhibitors for cancer therapy (2021-present)","volume":"29","author":"Abdel-Mohsen","year":"2024","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110399_bb0100","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s41120-024-00094-z","article-title":"Recent progress of small-molecule of RET inhibitors against non-small cell lung cancer","volume":"10","author":"Shen","year":"2024","journal-title":"AAPS Open"},{"issue":"12","key":"10.1016\/j.bioorg.2026.110399_bb0105","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1158\/1078-0432.CCR-06-2979","article-title":"AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis","volume":"13","author":"Wilkinson","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110399_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26071981","article-title":"Aurora kinase B inhibition: a potential therapeutic strategy for cancer","volume":"26","author":"Borah","year":"2021","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.bioorg.2026.110399_bb0115","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/cmdc.202100013","article-title":"Pyrazoloadenine inhibitors of the RET lung cancer oncoprotein discovered by a fragment optimization approach","volume":"16","author":"Saha","year":"2021","journal-title":"ChemMedChem"},{"issue":"7","key":"10.1016\/j.bioorg.2026.110399_bb0120","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nchembio799","article-title":"Rational design of inhibitors that bind to inactive kinase conformations","volume":"2","author":"Liu","year":"2006","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110399_bb0125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/scipharm91020018","article-title":"Medicinal chemistry of quinazolines as anticancer agents targeting tyrosine kinases","volume":"91","author":"Zayed","year":"2023","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.bioorg.2026.110399_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115717","article-title":"Exploring positions 6 and 7 of a quinazoline-based scaffold leads to changes in selectivity and potency towards RIPK2\/3 kinases","volume":"260","author":"Misehe","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"30","key":"10.1016\/j.bioorg.2026.110399_bb0135","doi-asserted-by":"crossref","first-page":"8717","DOI":"10.1002\/anie.201501104","article-title":"Fragment-based discovery of a dual pan-RET\/VEGFR2 kinase inhibitor optimized for single-agent polypharmacology","volume":"54","author":"Frett","year":"2015","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.bioorg.2026.110399_bb0140","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ejmech.2014.09.023","article-title":"Identification of two novel RET kinase inhibitors through MCR-based drug discovery: design, synthesis and evaluation","volume":"86","author":"Frett","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110399_bb0145","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1208\/s12248-019-0399-6","article-title":"Structural characterization of the Aurora kinase B \"DFG-flip\" using metadynamics","volume":"22","author":"Lakkaniga","year":"2019","journal-title":"AAPS J."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110399_bb0150","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1097\/JTO.0b013e3182721ed1","article-title":"Identification of CCDC6-RET fusion in the human lung adenocarcinoma cell line, LC-2\/ad","volume":"7","author":"Matsubara","year":"2012","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110399_bb0155","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nsb770","article-title":"Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site","volume":"9","author":"Pargellis","year":"2002","journal-title":"Nat. Struct. Biol."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110399_bb0160","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1002\/med.21581","article-title":"Molecular design opportunities presented by solvent-exposed regions of target proteins","volume":"39","author":"Jiang","year":"2019","journal-title":"Med. Res. Rev."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:01:02Z","timestamp":1791406862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826009351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":32,"alternative-id":["S0045206826009351"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110399","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of quinazoline-based dual RET\/Aurora B inhibitors for non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110399"}}